Miranda McEwan
Overview
Explore the profile of Miranda McEwan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McEwan M, Friedman S
Psychiatr Clin North Am
. 2016 Nov;
39(4):691-700.
PMID: 27836161
Psychiatrists are mandated to report suspicions of child abuse in America. Potential for harm to children should be considered when one is treating parents who are at risk. Although it...
2.
Rhodes J, McEwan M, Horsfield J
Mol Cancer Res
. 2011 Sep;
9(12):1587-607.
PMID: 21940756
Cohesin is a multisubunit protein complex that plays an integral role in sister chromatid cohesion, DNA repair, and meiosis. Of significance, both over- and underexpression of cohesin are associated with...
3.
McEwan M, Lins R, Munro S, Vincent Z, Ponnampalam A, Mitchell M
Cytokine Growth Factor Rev
. 2009 Jun;
20(3):241-9.
PMID: 19487153
The establishment of human pregnancy requires the orchestration of substantial cell differentiation and tissue remodelling processes in the context of a complex dialogue between the receptive endometrium and the implanting...
4.
Wilson T, McLaughlin K, McEwan M, Sakai H, Rogers K, Redmond K, et al.
Cancer Res
. 2007 Jun;
67(12):5754-62.
PMID: 17575142
c-FLIP is an inhibitor of apoptosis mediated by the death receptors Fas, DR4, and DR5 and is expressed as long (c-FLIP(L)) and short (c-FLIP(S)) splice forms. We found that small...
5.
Galligan L, Longley D, McEwan M, Wilson T, McLaughlin K, Johnston P
Mol Cancer Ther
. 2005 Dec;
4(12):2026-36.
PMID: 16373718
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has recently attracted attention as a potential therapeutic agent in the treatment of cancer. We assessed the roles of p53, TRAIL receptors, and cellular...